Cancer research has been rightly and successfully focused on prevention, early detection, and identification of specific molecular targets that distinguish the malignant cells from the neighbouring benign cells 1 . However, reducing lethal tissue injury caused by intensive chemoradiotherapy during treatment of late-stage metastatic cancers remains a key clinical challenge. Here we tested whether the induction of adult stem cells could repair chemoradiation-induced tissue injury and prolong overall survival in mice. We found that intestinal stem cells (ISCs) 2 expressed Slit2 and its single-span transmembrane cell-surface receptor roundabout 1 (Robo1) 3, 4 . Partial genetic deletion of Robo1 decreased ISC numbers and caused villus hypotrophy, whereas a Slit2 transgene increased ISC numbers and triggered villus hypertrophy. During lethal dosages of chemoradiation, administering a short pulse of R-spondin 1 (Rspo1; a Wnt agonist) [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] plus Slit2 reduced ISC loss, mitigated gut impairment and protected animals from death, without concomitantly decreasing tumour sensitivity to chemotherapy. Therefore Rspo1 and Slit2 may act as therapeutic adjuvants to enhance host tolerance to aggressive chemoradiotherapy for eradicating metastatic cancers.
With the use of two-colour fluorescent in situ hybridization (FISH), we found that Slit2 and Robo1 messenger RNAs not only co-localized, but also were expressed in markedly higher amounts in the crypts when compared to the villi in the small intestines of adult C57BL/6 (wild-type) mice ( Fig. 1a and Supplementary Fig. 1a ). Ki67 1 transient amplifying cells and Lgr5 1 ISCs expressed Slit2 and Robo1 mRNAs (Fig. 1b, c) . By contrast, neither Slit2 nor Robo1 mRNA was visible in lysozyme 1 Paneth cells. Using the intestinal specimens collected from Lgr5-enhanced green fluorescent protein (eGFP)-internal ribosome entry site (IRES)-CreERT2 (Lgr5-GFP) mice 15 , we confirmed that Slit2 and Robo1 mRNAs were expressed by GFP high ISCs at the bottom of the crypt (Fig. 1d ). The distribution of Slit2 and Robo1 is apparently higher at the crypts than in the villi of the small intestine, which mirrors the wellcharacterized gradient of active b-catenin in the crypt-villus axis 16 .
Complete or partial genetic deletion of Robo1 is embryonic lethal, whereas mice with partial genetic deletion of both Robo1 and Robo2 are viable 17, 18 . Thus, we examined the intestinal morphology in Robo1 1/2 Robo2 1/2 double heterozygotes (referred to here as Robo1/2 mutants). Robo1/2 mutants displayed reduced expression of Robo1 protein, but not Slit2 or a-tubulin ( Supplementary Fig. 2a ). Notably, Robo2 mRNA was not detectable in the wild-type small intestine, even though it clearly was present in the cerebellum ( Supplementary Fig. 1b ). Compared to wild-type littermates, Robo1/2 mutants had noticeably sparser, shorter and floppier villi throughout the entire small intestine ( Fig. 2a and Supplementary Fig. 3a ), displaying markedly fewer Ki67 1 transient amplifying cells (Fig. 2b ), Lgr5 1 ISCs (Fig. 2c ), villin (Vil1) 1 enterocytes (Fig. 2d) , and a reduced number of proliferating intestinal cells visualized by 5-bromodeoxyuridine (BrdU) staining ( Supplementary Fig. 4a ). The mutant animals also had a higher level of endotoxin ( Supplementary  Fig. 5 ), a functional indicator of intestinal impairment 13 . Importantly, Robo1 single heterozygotes (Robo1 1/2 or Robo1 mutants) phenocopied the Robo1/2 double heterozygotes ( Supplementary Fig. 6a-d) , whereas no such alterations were detected in the intestines of Robo2 single heterozygotes (Robo2 1/2 or Robo2 mutants; Supplementary Fig. 7a-d ). We also isolated intestinal crypts from Robo1/2 mutants and found that Robo1 1/2 Robo2 1/2 crypts failed to form intestinal organoids, also called mini-guts or enteroids [5] [6] [7] [8] , as compared to their wild-type littermates ( Fig. 2e , and Supplementary Fig. 8a for enlarged images). The expression of Lgr5, CD133 (also known as Prom1), Sox9, Bmi1 and mTERT (also known as Tert tm1Fish ) mRNAs as ISC markers 19 was significantly reduced in the Robo1/2 mutant intestines relative to their wild-type counterparts ( Supplementary Fig. 9a ). As Slit-Robo signalling re-models neovasculature 3 and induces epithelial-mesenchymal transition 4 , we examined and found no aberrant localization and distribution of CD31 (also known as Pecam1) 1 vascular endothelial cells in the vasculatures, including those distributing alongside the transient amplifying cell compartment and the capillary bed in the villi (Supplementary Fig. 10a, d ), or of a-smooth muscle actin 1 intestinal smooth muscle cells ( Supplementary Fig. 11a ) in the intestines of Robo1/2 mutants as compared to their wild-type littermates. These data collectively indicate that the Slit2-Robo1 interaction induces ISCs during physiological maintenance of intestinal homeostasis. To complement our genetic findings, we used R5, a monoclonal antibody that binds to Robo1, but not Robo2, Robo3 or Robo4, and neutralizes Slit2 binding to Robo1 (refs 3, 4) . Wild-type mice were treated daily for 6 days with an intraperitoneal injection of isotype-matched irrelevant mouse IgG or R5. As expected, R5, but not IgG, reduced intestinal villus size ( Supplementary Fig. 12a ) and number (Supplementary Fig. 3b ), decreased the numbers of Ki67 1 transient amplifying cells ( Supplementary Fig. 12b ), Lgr5 1 ISCs ( Supplementary Fig. 12c ), Vil1 1 enterocytes ( Supplementary Fig. 12d ) and BrdU 1 intestinal cells ( Supplementary Fig. 4b ), without concomitantly affecting the distributions of vascular endothelial cells ( Supplementary Fig. 10b , e) and smooth muscle cells ( Supplementary Fig. 11b ). Compared to IgG, R5 potently inhibited the in vitro formation of intestinal organoids [5] [6] [7] [8] isolated from wild-type mice (Supplementary Figs 12e, and 8b for enlarged images), and the expression of Lgr5, CD133, Sox9, Bmi1 and mTERT mRNAs 19 ( Supplementary Fig. 9b ).
We next asked whether ectopically expressed Slit2 (Robo1 ligand) might augment ISCs and their daughter cells, leading to villus hypertrophy. We therefore examined the intestinal phenotypic changes in Slit2 transgenic (Slit2-Tg) mice driven by the pCMV promoter for efficient but non-selective expression of human Slit2 transgene 20 . Compared to wild-type mice, Slit2-Tg mice displayed an increased mosaic expression of Slit2 protein, but not Robo1 or a-tubulin, in the small intestines ( Supplementary Fig. 2b ). When compared to wild-type mice, Slit2-Tg mice had noticeably thicker, longer, enlarged and outnumbered villi ( Fig. 3a and Supplementary Fig. 3c ), with increased numbers of Ki67 1 transient amplifying cells (Fig. 3b ), Lgr5 1 ISCs (Fig. 3c ), BrdU 1 intestinal cells ( Supplementary Fig. 4c ) and Vil1 1 enterocytes ( Fig. 3d ), without concomitantly affecting the distribution of CD31 1 vascular endothelial cells ( Supplementary Fig. 10c , f) or a-smooth muscle actin 1 smooth muscle cells ( Supplementary Fig. 11c ). The compartment of Ki67 1 transient amplifying cells appeared to be enlarged, which could be caused by accelerated proliferation ( Supplementary Fig. 4c ) and/or aberrant directional migration of transient amplifying cells triggered by Slit-Robo signalling 3, 4 . Notably, the intestinal crypts isolated from Slit2-Tg mice formed more and larger intestinal organoids [5] [6] [7] [8] relative to their wild-type counterparts ( Fig. 3e , and Supplementary Fig. 8c for enlarged images). Compared to wild-type mice, the expression of Lgr5, CD133, Sox9, Bmi1 and mTERT mRNAs 19 ( Supplementary Fig. 9c ) was significantly augmented in the small intestine of Slit2-Tg mice. Taken together, our results indicate the functional significance of Slit-Robo signalling in intestinal regeneration through modulation of ISCs. 
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We further tested whether recombinant Slit2 (rSlit2 (ref. 4)) could substitute and potentiate recombinant Rspo1 (rRspo1; Supplementary  Fig. 13a ) for inducing intestinal organoids in vitro. As predicted, rSlit2 acted synergistically with rRspo1 to promote in vitro formation and growth of intestinal organoids in terms of their number and size (Supplementary Figs 14a, and 8d for enlarged images). In the absence of rRspo1 (rRspo12), rSlit2 alone-at 0.5 or 1 mg ml 21 -was capable of inducing intestinal organoids. The intestinal crypts isolated from Slit2-Tg mice also formed intestinal organoids without added rRspo1 or rSlit2. Using single cell sorting gated for GFP 5 , we isolated GFP high ISCs from Lgr5-GFP mice 15 and found that rSlit2 by itself induced intestinal organoids ( Supplementary Figs 14b, and 8e for enlarged images). Importantly, rSlit2 acted cooperatively with rRspo1 in the formation of intestinal organoids in vitro. To further demonstrate whether Slit2 could induce the self-renewal and pluripotential capacities of ISCs, we performed serial passages (up to four passages; every 2 weeks for each passage) of cultured intestinal organoids and found that rSlit2 not only substituted for rRspo1, but also functioned synergistically with rRspo1, using both the isolated wild-type intestinal crypts ( Supplementary  Fig. 15a ) and the sorted GFP high ISCs ( Supplementary Fig. 15b ).
Considering that Lgr5 is a specific ISC marker 15 and a direct targeting gene of canonical Wnt signalling 2,5-8 , we treated Lgr5-GFP mice with mIgG and R5 and found that, compared to untreated (normal) or IgG-treated Lgr5-GFP mice, R5 inhibited the number of GFP high ISCs (,50% inhibition; Supplementary Fig. 16a ). Compared to untreated Lgr5-GFP mice, treatment with rRspo1 plus rSlit2 increased the number of GFP high ISCs (,30% increase; Supplementary Fig. 16b ). Treatment with rRspo1 or rSlit2 alone also slightly augmented the number of GFP high ISCs. Our results thus provide in vivo evidence for the biological importance of our newly discovered Slit2 and Rspo1 cooperation in the induction of ISCs and the activation of Wnt/b-catenin signalling.
We also tested the functional importance of Robo1 in Rspo1-induced intestinal repair in vivo. Consistent with previous reports 9-14 , intravenous administration of rRspo1 potently promoted villus growth in the wild-type jejunum ( Supplementary Fig. 17a) . Surprisingly, rRspo1 (0.1 mg per mouse per day for 5 days) failed to accelerate growth of intestinal epithelial cells in Robo1/2 mutants. Compared to their rRspo1-treated wild-type counterparts, rRspo1 also failed to significantly augment the numbers of Lgr5 1 ISCs ( Supplementary Fig. 17b ) and Ki67 1 transient amplifying cells ( Supplementary Fig. 17c ) in the jejunum crypts of Robo1/2 mutants. A prolonged pulse of rRspo1 (0.1 mg per mouse per day for 10 days) robustly enhanced crypt size ( Supplementary Fig. 18a ) and augmented the numbers of Ki67 1 transient amplifying cells (Supplementary Fig. 18b ), BrdU 1 intestinal cells ( Supplementary Fig. 18c ) and Lgr5 1 ISCs ( Supplementary Fig. 18d ) in wild-type littermates, but not in Robo1/2 mutants. As predicted, treatment of wild-type littermates with rRspo1 markedly induced the cytoplasmic and nuclear translocation of b-catenin ( Supplementary Fig. 19a ) and increased the expression of c-Myc ( Supplementary Fig. 19b ) compared to Robo1/2 mutants.
Stimulation of Wnt/b-catenin signalling with Rspo1 can ameliorate 5-fluorouracil (5-FU) and radiation-induced gut damage, including radiation-induced gastrointestinal syndrome (RIGS) [9] [10] [11] [12] [13] . Relatedly, we found that the therapeutic dosage of 5-FU 9 , a well-characterized chemotherapy medicine, markedly shortened the villus length (Supplementary Fig. 20a ) and reduced the numbers of Lgr5 1 ISCs ( Supplementary  Fig. 20b ) and Ki67 1 transient amplifying cells ( Supplementary Fig. 20c ) in the wild-type jejunum, but not in the Slit2-Tg jejunum. These 
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findings demonstrate the functional significance of Slit2 for promoting chemotherapy-induced intestinal repair. Considering our findings that Slit2 potentiated Rspo1-induced ISCs and synergized with Rspo1 for reducing chemotherapy-induced gut injury, we asked whether Slit2, in combination with Rspo1, could induce ISCs and consequently prolong overall survival in mice receiving lethal challenges of chemoradiation. Surprisingly, in mice with the Slit2 transgene, there was a 70% survival rate in mice receiving a lethal dose of 5-FU 21 , whereas this same dosage caused the death of all wild-type mice within 2 weeks (Fig. 4a) . The lethal dose of 5-FU abolished .90% of GFP high ISCs ( Supplementary Fig. 21a ). However, a 3-day treatment of rSlit2 or rRspo1 alone protected ,40% of GFP high ISCs. A notable finding was that the same regimen of rRspo1 plus rSlit2 preserved ,80% of GFP high ISCs. Our findings thus indicate that Slit2 acts synergistically with Rspo1 for cooperative induction of ISCs, leading to prolongation of overall survival in response to the lethal dose of chemotherapy.
Because aberrant Wnt signalling causally contributes to colorectal carcinogenesis 2 , because Slit2 and Robo1 expression inversely correlates with the overall survival rate in colorectal cancer 4 , and because recurrent gene fusion of Rspo2 and Rspo3 contributes to colorectal cancer 22 , we explored whether a short 3-day pulse of rSlit2 and/or rRspo1 could accelerate the development of intestinal carcinogenesis and/or decrease its sensitivity to chemoradiotherapy. To test this, Apc Min/1 mice with spontaneous intestinal adenomas were treated with dextran sulphate sodium (DSS) to induce inflammation-related intestinal carcinogenesis, a murine model that is thought to closely mimic multifactorial human colorectal cancer 23 . Treatment of DSS-treated Apc Min/1 mice with rSlit2 or rRspo1 alone led to a 20-30% survival rate upon the lethal dosage of 5-FU (Fig. 4b) . Importantly, a combination of rSlit2 and rRspo1 led to a 60% survival rate (P 5 0.003 between the rRspo1 plus rSlit2 group compared to either group alone), demonstrating the functional cooperation between Slit2 and Rspo1 leading to increased host tolerance to the lethal dose of chemotherapy in this murine model of carcinogenesis.
Consistent with previous reports using recombinant flagellin in xenografted mouse sarcoma and malignant melanoma 24 and adenoviral Rspo1 in xenografted human colorectal carcinoma 12 , neither acceleration of intestinal cancer development nor desensitization to 5-FU chemotherapy was detected with our rRspo1 and rSlit2 combination treatment (Fig. 4c) . By contrast, upon administration of rRspo1 and rSlit2, a single 'lethal' dose of 5-FU markedly eliminated the number of intestinal tumours, suggesting that Rspo1 plus Slit2 treatment may act as adjuvants before, during or after intensive chemotherapy for cancer eradication.
Furthermore, the combination of rSlit2 plus rRspo1 led to a 30% survival rate in mice receiving a lethal dose of whole body irradiation (WBI; Fig. 4d ) and a 50% survival rate in mice receiving a lethal dose of abdominal irradiation (AIR; Fig. 4h ). We also observed concomitant prolongations of the villus length ( Fig. 4e, i) , augmentations of Lgr5 1 ISCs (Fig. 4f, j) and Ki67 1 transient amplifying cells (Fig. 4g, k) in the jejunum, which are in analogous to previous finding that Lgr5 1 ISCs in the small intestine are resistant to radiation 25 . Mechanistically, although the lethal dose of WBI abolished .80% of GFP high ISCs ( Supplementary  Fig. 21b ), a 3-day treatment of rRspo1 or rSlit2 alone protected ,40% 
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of GFP high -ISCs, whereas rRspo1 plus rSlit2 preserved .80% of GFP high ISCs in Lgr5-GFP mice.
In summary, our study indicates that Slit2 and Rspo1 cooperatively induce ISCs for intestinal homeostasis and repair and significantly prolong overall survival following lethal doses of chemoradiotherapy. To the best of our knowledge, the combined Slit2/Rspo1 treatment, used as an adjuvant approach, is the first example to demonstrate the feasibility of inducing endogenous adult tissue-specific stem cells for organ and tissue repair with far-reaching medical impact.
METHODS SUMMARY
Linearized DIG or biotin-labelled antisense or sense RNA probes for murine Slit2, Robo1 and Robo2 were employed for FISH. Various strains of genetic engineering mice were either untreated or treated with mouse IgG versus R5, DSS, 5-FU versus irradiation, rSlit2 and/or rRspo1, or BrdU. The tissue specimens of mouse small intestines were collected and examined by various histological, immunohistological and immunofluorescent staining methods. The isolated crypts of mouse small intestines were cultured in vitro. The baculovirus expression system was used to express rSlit2, rRspo1 and rNog in Sf9 insect cells, which were affinity purified to homogeneity from their corresponding serum-free media.
METHODS
Mouse experiments and histology. C57BL6/J (wild type; stock no. 005304), Lgr5-eGFP-IRES-CreERT2 (Lgr5-GFP; stock no. 008875) 15 and Apc Min/1 (stock no. 002020) mice were purchased from Jackson Laboratory. Robo1 1/2 Robo2 1/2 mice 17,18 were purchased from MMRRC/University of Missouri and their wildtype littermates were used as controls. During the process of expanding our cohort of Robo1 1/2 Robo2 1/2 mice, we unexpectedly obtained several adult single Robo1 (Robo1 1/2 ; less than 3% of total mouse population) or Robo2 (Robo2 1/2 ) heterozygotes that were not embryonically lethal. Notably, we have never obtained any viable Robo1 2/2 homozygotes after multiple trials. Slit2-Tg mice were generated and characterized as described 20 . Male and female mice were equally divided without randomization. They were used at 8 weeks old unless specifically indicated. For measurement of cell proliferation, mice were injected with BrdU (1 mg per 100 g of body weight) for 2 h before euthanization. For antibody treatment, wild-type mice were injected intraperitoneally with isotype-matched irrelevant mouse IgG or R5 monoclonal antobody 3, 4 (1 mg per mouse per day for 6 consecutive days). For induction of inflammation-related intestinal carcinogenesis, Apc Min/1 mice were treated with 2% DSS in drinking water for 1 week and were used experimentally 2 weeks later 23 . For 'chemoradiation' experiments, wild-type and DSS-treated Apc Min/1 mice (10 weeks old) were injected intravenously with Slit2 or Rspo1 alone or in combination (0.1 mg per mouse per day for three consecutive days). On day 2, they were given 5-FU intraperitoneally (30 mg per kg per mouse per day for 5 days for the therapeutic dose 9 or 300 mg kg 21 once for the lethal high dose 21 ) or were irradiated (10.4 Gy per mouse once for WBI or 12 Gy per mouse once for AIR 12 ). Alternatively, Slit2-Tg mice 20 (10 weeks old) were given the lethal high dose of 5-FU intraperitoneally (300 mg kg 21 once 21 ). Tissue sections of small intestines were stained with H&E and the relative villus sizes and numbers at the duodenum, jejunum and ileum were double-blindly measured. The length ratios of 1:3:2 of the entire small intestine were defined as the duodenum, jejunum and ileum 26 Immunofluorescent and immunohistochemical staining. Intestinal tissues were fixed with 4% paraformaldehyde, sectioned (5-mm thick) and permeabilized with 0.05% Triton X-100 in PBS, pH 7.4. Samples were blocked with 1% BSA (Sigma) and incubated with primary antibody at 37 uC for 1 h, including antibodies against Ki67 (ab15580, Abcam), Lgr5 (ab75850, Abcam), lysozyme (ab36362, Abcam), CD31 (ab28364, Abcam), a-smooth muscle actin (ab5694, Abcam), Vil1 (610358, BD Biosciences), c-Myc (sc-40, Santa Cruz Biotechnology), GFP (NB600-303, Novus Biologicals) and BrdU (B2531, Sigma Aldrich). After washing extensively, samples were incubated with appropriate fluorescent dye-or HRP-conjugated secondary antibody at 37 uC for 1 h. Sections were counterstained with DAPI or H&E. Slides were then washed and mounted for observation under a scanning confocal microscope (Leica TCS SP2) or a fluorescence stereomicroscope (Leica M205 FA). The immunohistochemical staining data were quantified double blindly using ImageTool Software. In vitro culture of intestinal crypts. The intestinal crypts of mouse small intestines were isolated 28 and cultured in vitro [5] [6] [7] [8] . Specifically, mouse ileums (,6 cm) were dissected out of the animals, flushed with ice-cold sterile PBS, cut open lengthwise and into 1-cm pieces, and transferred into the Petri dish with ice-cold sterile PBS supplemented with 1% penicillin/streptomycin (Invitrogen). This step was repeated twice. They were then transferred to a 50-ml conical tube containing 30 ml of ice-cold sterile shaking buffer (PBS supplemented with 15 mM EDTA and 1% penicillin/streptomycin) and rocked in the cold room for 30 min, then vortexed at maximal speed for a total of 2 min in 30-s intervals. The shaking buffers containing separated crypts were filtered through a 70-mm filter into a new 50-ml conical tube, counted, transferred to a round-bottom tube (500 crypts per tube), and centrifuged at 200g at 4 uC for 10 min. After gently removing the supernatant, the crypt pellets were re-suspended in 20 ml of the gut media (Advanced DMEM/F12, 1% L-glutamine, 1% penicillin/streptomycin, 10 mM HEPES (all from Invitrogen), 1% N2 supplement (R&D Systems), 2% B27 supplement (Invitrogen), 0.5 mg ml 21 rRspo1 ( Supplementary Fig. 13a ), 0.1 mg ml 21 rNog ( Supplementary  Fig. 13b ), 0.1 mg ml 21 EGF (R&D Systems), 0.1 mg ml 21 rWnt3a (R&D Systems) or 0.5 or 1 mg ml 21 rSlit2 (ref. 4)). These crypts were mixed with ice-cold 50 ml Matrigel (BD Biosciences) and plated onto one well of the 24-well cell culture plate, using a pre-chilled pipette tip. The plate was placed in the 37 uC incubator for 30 min and an aliquot of 0.5 ml gut media was overlaid. The media was replaced every 2-4 days.
Isolation and cell sorting of GFP-positive ISCs expressing Lgr5-GFP was performed according to the previous publication 10 . Specifically, the small intestinal crypts of Lgr5-GFP mice were isolated and dissociated with TrypLE express (Invitrogen) and 2,000 U ml 21 DNase (Sigma Aldrich) at 37 uC for 30 min. Dissociated cells were passed through a 20-mm cell strainer and washed with sterile PBS. GFP high ISCs were isolated using Moflo cell sorter. An aliquot of 10,000 sorted GFP high ISCs were suspended in 20 ml gut media, mixed well with 50 ml Matrigel, and transferred to one well of 24-well plate. The plate was placed in the 37 uC incubator for 30 min and an aliquot of 0.5 ml gut media supplemented with Y-27632 (10 mM, to prevent anoikis; Sigma Aldrich) was overlaid. The efficiency of organoids generation from isolated GFP high ISCs was ,3%, which was similar to the previous reports 5, 29 . Indicated growth factors were added every other day and the entire medium was changed every 4 days. For serial passage, the cultured intestinal organoids were removed from the Matrigel culture and mechanically dissociated into the single crypt domains. After mixing with gut media and Matrigel, they were transferred to the new well and an aliquot of 0.5 ml gut media was overlaid. This procedure was repeated during a 2-week period, without loss of replicating efficiency. Isolation and quantification of GFP 1 ISCs. The small intestinal crypts of Lgr5-GFP mice were isolated and dissociated with TrypLE express (Invitrogen) and 2,000 U ml 21 DNase (Sigma Aldrich) at 37 uC for 30 min. Dissociated cells were passed through a 20-mm cell strainer and washed with sterile PBS. GFP high ISCs were stained with the anti-GFP antibody (NB600-303, Novus Biologicals), followed by an appropriate FITC-conjugated secondary antibody for quantification by flow cytometry. Quantitative (q)RT-PCR. All mouse qRT-PCR primer pairs were purchased from SA Biosciences. The crypts of mouse small intestine were isolated 28 for qRT-PCR as previously described 4 . Notably, we routinely isolated smaller amounts of total mRNAs from the atrophied Robo1/2 and R5-treated intestines and higher amounts of total mRNAs from the hypertrophied Slit2-Tg intestines than the wild-type intestines (data not shown). However, the adjusted amounts of total isolated mRNAs were used as the starting materials in the identical quantity for the purpose of comparison.
Immunoblotting. The isolated intestinal crypts were washed with ice-cold PBS, pH 7.4, and lysed with ice-cold radioimmunoprecipitation assay lysis buffer (50 mM Tris-HCl, pH 7.4, 150 mM NaCl, 1 mM sodium orthovanadate, 10 mM sodium fluoride, 1 mM phenylmethylsulfonyl fluoride, 2 mg ml 21 aprotinin, 2 mg ml 21 leupeptin, 1 mg ml 21 pepstatin A, 15 mg ml 21 benzamidine, 0.5% Nonidet P-40, 0.15% BSA and 10% glycerol) at 4 uC for 1 h. Samples were centrifuged at 12,000g for 15 min at 4 uC. Samples were subjected to SDS-PAGE, transferred to polyvinylidene difluoride (PVDF) membranes (EMD Millipore) and detected with appropriate primary antibodies followed by HRP-conjugated goat anti-mouse or rabbit IgG. The blotting signals were detected using SuperSignal West Dura Extended Duration Substrate (Pierce). Quantitative analyses of immunoblotting signals on Fuji Films were obtained by densitometry analysis using LAS4000 Image Software. Notably, we routinely isolated smaller amounts of total proteins from the atrophied Robo1/2 and R5-treated intestines and higher amounts of total proteins from the hypertrophied Slit2-Tg intestines than the wild-type intestines (data not shown). However, the adjusted amounts of total isolated proteins were used as the starting materials in the identical quantity for the purpose of comparison. The primary antibodies against pan-Slit and Robo1 (S1 and R4 (refs 3, 4)), a-tubulin (T6074, Sigma Aldrich) and b-actin (A1978, BD Biosciences) were used. Baculovirus expression of Rspo1 and Nog. The cDNAs of human Rspo1 and Nog (Open Biosystems) were amplified for construction of 6-His fusion proteins, using the forward primer 59-TTGCGGCCGCATGCGGCTTGGGCTGTG-39 and the reverse primer 59-GGGAATTCGGCAGGCCCTGCAGATGTGAGTGGCC-39 for Rspo1, and the forward primer 59-TAGCGGCCGCATGGAGCGCTGCCCC-39 and the reverse primer 59-GGGAATTCGCACGAGCACTTGCACTCGGAATG ATGG-39 for Nog. The inserts of Rspo1 and Nog were digested with NotI/EcoRI. They were ligated into the pVL1392 vector (BD Pharmingen).
Recombinant Rspo1 and Nog were expressed in Sf9 insect cells using the baculovirus expression system (BaculoGold; BD Pharmingen) and purified to homogeneity from the serum-free supernatant of Sf9 cells infected with their respective viral stocks (multiplicity of infection ,2 3 10 8 ml 21 ) by Talon metal affinity chromatography (BD Clontech) 30 . Endotoxin levels of these isolated recombinant proteins RESEARCH LETTER
